Karpas-620Homo sapiens (Human)Cancer cell line

Also known as: K620, KARPAS620, Karpas620, KARPAS 620, Karpas 620, KARPAS-620

🤖 AI SummaryBased on 14 publications

Quick Overview

Human multiple myeloma cell line with B-cell lineage and specific chromosomal translocations.

Detailed Summary

Karpas-620 is a human multiple myeloma cell line derived from a plasma cell leukemia patient. It exhibits a complex karyotype with multiple chromosomal translocations involving chromosomes 1, 8, 11, and 14. The cell line is characterized by the expression of plasma cell markers such as CD138 and the presence of immunoglobulin light chains. It has been used in studies related to myeloma biology, including investigations into the role of MYC and Cyclin D1 in tumor progression. Karpas-620 is also noted for its IL-6 dependency and has been utilized in research on the NF-κB pathway and its implications in myeloma pathogenesis.

Research Applications

Myeloma biologyTranslocation analysisNF-κB pathway studiesIL-6 dependencyMYC and Cyclin D1 expression

Key Characteristics

Complex karyotype with translocationsIL-6 dependent growthExpression of plasma cell markersMYC and Cyclin D1 overexpression
Generated on 6/17/2025

Basic Information

Database IDCVCL_1823
SpeciesHomo sapiens (Human)
Tissue SourcePeripheral blood[UBERON:UBERON_0000178]

Donor Information

Age77
Age CategoryAdult
SexFemale

Disease Information

DiseaseMultiple myeloma
LineageLymphoid
SubtypePlasma Cell Myeloma
OncoTree CodePCM

DepMap Information

Source TypeDSMZ
Source IDACH-000193_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Cys135Tyr (c.404G>A)Unspecified-PubMed=21173094
MutationSimpleKRASp.Gly12Asp (c.35G>A)Unspecified-PubMed=29786757

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
9,10
D13S317
12,14
D16S539
11,12
D18S51
13,18
D19S433
12,13
D21S11
29,31.2
D2S1338
18,19
D3S1358
14,16
D5S818
9,11
D7S820
9
D8S1179
10
FGA
26
Penta D
10,13
Penta E
14,15
TH01
6,7
TPOX
11,12
vWA
17,19
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis.

Sirota M., Wiita A.P.

Leukemia 34:2754-2765(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways.

Pellat-Deceunynck C.

J. Hematol. Oncol. 11:137.1-137.13(2018).

Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

Yang H.H., Koeffler H.P.

BMC Cancer 18:940.1-940.13(2018).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A simple flow cytometry-based barcode for routine authentication of multiple myeloma and mantle cell lymphoma cell lines.

Moreau-Aubry A., Amiot M., Pellat-Deceunynck C.

Cytometry A 87:285-288(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines.

Pellat-Deceunynck C.

Haematologica 96:574-582(2011).

A der(8)t(8;11) chromosome in the Karpas-620 myeloma cell line expresses only cyclin D1: yet both cyclin D1 and MYC are repositioned in close proximity to the 3'IGH enhancer.

Dib A., Glebov O.K., Shou Y.-P., Singer R.H., Kuehl W.M.

DNA Repair 8:330-335(2009).

Characterization of MYC translocations in multiple myeloma cell lines.

Dib A., Gabrea A., Glebov O.K., Bergsagel P.L., Kuehl W.M.

J. Natl. Cancer Inst. Monogr. 39:25-31(2008).

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

Stewart A.K., Carpten J.D., Bergsagel P.L.

Cancer Cell 12:131-144(2007).

The phenotype of normal, reactive and malignant plasma cells. Identification of 'many and multiple myelomas' and of new targets for myeloma therapy.

Moreau P., Amiot M., Pellat-Deceunynck C.

Haematologica 91:1234-1240(2006).

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma.

Kuehl W.M., Bergsagel P.L.

Blood 97:729-736(2001).

Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia.

Drexler H.G., Matsuo Y.

Leuk. Res. 24:681-703(2000).

A new human plasma cell line, Karpas 620, with translocations involving chromosomes 1, 11 and 14.

Conneally E., Blaney C., Hayhoe F.G.J., Karpas A.

Br. J. Haematol. 74:70-76(1990).

The leukemia-lymphoma cell line factsbook.";

Drexler H.G.

(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).

Multiple myeloma cell lines.";

Jernberg-Wiklund H., Nilsson K.

(In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000).

Web Resources